Difficulty: Medium
Average Score: 67%
Practice
A patient with idiopathic pulmonary arterial hypertension (IPAH) is receiving nifedipine (Procardia). Which assessment would best indicate to the nurse that the patient's condition is improving?
Correct answer
C
Rationale
In the context of a patient with idiopathic pulmonary arterial hypertension (IPAH) receiving nifedipine, the best indicator of improvement in the patient's condition is their report of a decrease in exertional dyspnea (Option C). Decreased dyspnea signifies improved pulmonary artery pressure and oxygenation, which are key treatment goals in IPAH management. This symptom directly reflects how well the medication is working to alleviate the pressure on the pulmonary arteries, allowing for improved oxygen exchange in the lungs.
Option A, the chest x-ray indicating clear lung fields, while important, may not always directly correlate with the patient's symptomatic improvement or the effectiveness of the medication in managing IPAH.
Option B, heart rate between 60 and 100 beats/minute, is a general parameter for heart rate control but does not specifically address the improvement in pulmonary hypertension or oxygenation in IPAH.
Option D, blood pressure less than 140/90 mm Hg, is a parameter for blood pressure control and is not directly related to the improvement in IPAH symptoms, such as dyspnea.
Educationally, understanding the rationale behind selecting the most appropriate assessment parameter in monitoring patients with IPAH on nifedipine is crucial for nurses and healthcare providers. It highlights the importance of focusing on specific symptoms related to the condition being treated and how they can be used to evaluate the effectiveness of the therapy provided. This knowledge enhances the quality of patient care by ensuring that assessments are tailored to monitor the relevant aspects of the patient's condition accurately.
Option A, the chest x-ray indicating clear lung fields, while important, may not always directly correlate with the patient's symptomatic improvement or the effectiveness of the medication in managing IPAH.
Option B, heart rate between 60 and 100 beats/minute, is a general parameter for heart rate control but does not specifically address the improvement in pulmonary hypertension or oxygenation in IPAH.
Option D, blood pressure less than 140/90 mm Hg, is a parameter for blood pressure control and is not directly related to the improvement in IPAH symptoms, such as dyspnea.
Educationally, understanding the rationale behind selecting the most appropriate assessment parameter in monitoring patients with IPAH on nifedipine is crucial for nurses and healthcare providers. It highlights the importance of focusing on specific symptoms related to the condition being treated and how they can be used to evaluate the effectiveness of the therapy provided. This knowledge enhances the quality of patient care by ensuring that assessments are tailored to monitor the relevant aspects of the patient's condition accurately.